BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2009
View Archived Issues
New HCV RNA-dependent RNA polymerase NS5B inhibitors developed at GSK
Read More
Bayer reports novel prostacyclin PGI2 receptor agonists
Read More
Dual-action inhibitors of Tie2 and KDR kinase prepared and tested at Bayer Schering Pharma
Read More
Novel SSTR5 antagonists with antidiabetic properties developed at Roche
Read More
AstraZeneca claims new chemokine CCR1 receptor ligands as antiasthmatic agents
Read More
Trius completes enrollment in phase II torezolid trial in cSSSI
Read More
Rib-X announces positive phase II study results for delafloxacin in cSSSI
Read More
Halozyme presents positive preclinical data for PEGPH-20
Read More
Rexahn completes patient enrollment in phase IIa clinical trial of Zoraxel for ED
Read More
MAP completes patient enrollment in phase III clinical trial of MAP-0004
Read More
ImClone and Bristol-Myers Squibb withdraw and are to resubmit sBLA for Erbitux
Read More
Plerixafor mobilizes different progenitor cell subsets when given with G-CSF or VEGF
Read More
Antitope and Opsona generate new therapeutic antibody Opn-305
Read More
Levosimendan a potential treatment for chronic obstructive pulmonary disease
Read More
Tripep initiates phase II study in Norway and Sweden of ChronSeal for chronic leg wounds
Read More
Onconova successfully completes first dose cohort of phase I clinical trial of Ex-RAD
Read More
BioInvent and ThromboGenics receive technology transfer success fee for TB-403
Read More
Crucell and Wyeth discontinue discussions on possible combination
Read More
Debiopharm randomizes first patient in phase IIb Debio-025 hepatitis C trial
Read More
Pfizer to acquire Wyeth under definitive merger agreement
Read More
KV receives notice of delayed NDA approval for Gestiva
Read More
Basilea focuses on commercialization of its products and high priority programs
Read More
CTI to begin rolling NDA submission for pixantrone for non-Hodgkin's lymphoma
Read More
FDA accepts Sirion's ganciclovir NDA for review for treatment of ocular herpes
Read More
Seattle Genetics receives FDA and EMEA orphan drug designations for SGN-35
Read More